get a key
steadybase-$ company TOVX
account_id none on file
legal_name Theriva Biologics, Inc.
ticker TOVX
cik 894158
domain therivabio.com
entry_point_account_id none on file
name Theriva Biologics Inc.
exchange NYSE
sector Health Care
hq Rockville, MD, United States
calls 0 filings 7 executives 3 family 0
why_nownone on file
callsnone on file
filings
Pursuant to the Plan, on September 30, 2025, the Company implemented a workforce reduction of seven employees or 32 % of the then global Company workforce.

filing / Aug 11, 2026 / receipt

The Company completed the employee reduction immediately and incurred a total of approximately $ 520,000 in charges in connection with the workforce reduction.

filing / Aug 11, 2026 / receipt

calendar year ending on or preceding the date of termination, expense reimbursement and any other entitlements accrued by him to the extent

filing / Jun 29, 2026 / receipt

Shallcross was appointed as our Interim Chief Executive Officer on December 5, 2017 and has served as our Chief Financial Officer since joining us in June 2015.

filing / Jun 29, 2026 / receipt

he was appointed to on December 6, 2018, and our Chief Financial Officer. Mr. Shallcross was appointed as our Interim Chief

filing / Jun 29, 2026 / receipt

potentially means extra convenience for stockholders and cost savings for companies and intermediaries. A number of brokers and other

filing / Jun 29, 2026 / receipt

should we engage in a strategic transaction that results in the hiring of additional employees, the remaining awards may not be sufficient

filing / Jun 29, 2026 / receipt

executives
David A. Newsome Chief Scientific Officer - receipt
Max Lyon President and Chief Executive Officer - receipt
Steven A. Shallcross Interim Chief Executive Officer linkedin receipt
familynone on file
upcoming
2026-11-11 earnings call scheduled ir
changes
2017-12-07 Interim Chief Executive Officer, appointed sec_8k
2009-08-26 director, departed sec_8k
2009-07-02 President and Chief Executive Officer, appointed sec_8k
2009-07-02 President and Chief Executive Officer, departed sec_8k
2008-07-08 Chief Executive Officer, appointed sec_8k
2008-07-08 Director, departed sec_8k
2008-07-08 Director, departed sec_8k
2007-10-16 Chief Scientific Officer, appointed sec_8k
mcp_package_hint
steadybase-$